
Virtus LifeSci Biotech Products ETF (BBP) Price & Chart
BBP ETF Chart & Stats
- Day’s Range
- $101.68 - $103.14
- 52-Week Range
- $72.81 - $110.05
- Previous Close
- $102.07
- Volume
- 9,360
- Average Volume (3M)
- 12.19K
- AUM
- 127.72M
- NAV
- 102.39
- Expense Ratio
- 0.34%
- Holdings Count
- 66
- Beta
- 0.92
- Inception Date
- Dec 17, 2014
- Last Dividend Ex-Date
- Dec 20, 2017
- Dividend Yield
- (0.07%)
- Shares Outstanding
- 1,250,004
- Standard Deviation
- N/A
ETF Overview
Virtus LifeSci Biotech Products ETF
The Virtus LifeSci Biotech Products ETF (Ticker: BBP) offers investors a targeted opportunity to delve into the dynamic and rapidly evolving biotechnology sector within the broader health care industry. Specializing in biotech companies, BBP is designed to capture the growth potential of firms at the cutting-edge of scientific innovation and medical advancements. This ETF focuses exclusively on firms involved in the development, production, and commercialization of biotechnology products, making it an ideal choice for investors seeking exposure to groundbreaking therapeutics and technologies that are reshaping the future of medicine. By investing in BBP, stakeholders gain access to a curated portfolio of pioneering biotech companies, offering a blend of established leaders and emerging innovators poised for substantial growth. Whether you are looking to tap into the transformative possibilities of biotechnology or aiming to diversify your investment portfolio with sector-specific exposure, the Virtus LifeSci Biotech Products ETF provides a strategic window into the forefront of health care innovation.
Virtus LifeSci Biotech Products ETF (BBP) Fund Flow Chart
BBP ETF News
BBP ETF FAQ
What was BBP’s price range in the past 12 months?
What is the AUM of BBP?
Is BBP overvalued?
Does BBP pay dividends?
How many shares outstanding does BBP have?
BBP ETF Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| MRNAModerna | 5.25% |
| IOVAIovance Biotherapeutics | 4.45% |
| VSTMVerastem Inc | 3.21% |
| OMEROmeros Corporation | 2.46% |
| HALOHalozyme Therapeutics | 2.43% |
| RIGLRigel Pharmaceuticals | 2.00% |
| XERSXeris Pharmaceuticals | 1.98% |
| ZLABZai Lab Ltd | 1.88% |
| KNSAKiniksa Pharmaceuticals Ltd. Class A | 1.85% |
| ONCBeOne Medicines | 1.85% |
| Total | 27.34% |
